Apimeds Pharmaceuticals US, Inc. - Common Stock (APUS) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
APUS on NYSE
Shares outstanding
12,584,892
Price per share
$1.87
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
399,983
Total reported value
$711,810
% of total 13F portfolios
0%
Share change
+121,452
Value change
+$221,594
Number of holders
8
Price from insider filings
$1.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Apimeds Pharmaceuticals US, Inc. - Common Stock (APUS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Inscobee Inc. 34% -9.5% $8,460,571 -$139,336 4,316,618 -1.6% Apimeds Inc. 01 Dec 2025

As of 30 Sep 2025, 8 institutional investors reported holding 399,983 shares of Apimeds Pharmaceuticals US, Inc. - Common Stock (APUS). This represents 3.2% of the company’s total 12,584,892 outstanding shares.

Institutional Holders of Apimeds Pharmaceuticals US, Inc. - Common Stock (APUS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 333,574 $547,061 +$40,314 $1.64 3
2025 Q3 399,983 $711,810 +$221,594 $1.78 8
2025 Q2 278,531 $490,216 +$50,216 $1.76 6